The JAMA Internal Medicine study on a food-as-medicine programme revealed mixed outcomes for participants with type 2 diabetes and high HbA1c levels. While not significantly impacting glycemic control, the intervention notably enhanced preventive healthcare engagement. The treatment group demonstrated increased dietician visits, prescription orders, and reported dietary improvements compared to the control group. Despite these advancements, both groups experienced considerable reductions in HbA1c levels. Interviewed by Healio, Joseph Doyle highlighted the unexpected findings, acknowledging the challenges of improving markers among highly engaged patients. He emphasised the need for robust evidence in the food-as-medicine landscape and suggested using free food incentives to enhance patient engagement and explore alternate delivery methods for tailored meals.
Global News and Digital Insights
for the Healthcare Industry
Menu
